• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.3733 -0.0045 (-1.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 778,162
Open 0.3705
Bid (Size) 0.3630 (100)
Ask (Size) 0.3748 (58,500)
Prev. Close 0.3778
Today's Range 0.3624 - 0.3745
52wk Range 0.2300 - 2.750
Shares Outstanding 3,541,262
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
August 20, 2026
From Ensysce Biosciences
Via ACCESS Newswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
August 14, 2026
Via Chartmill

Performance

YTD
-60.3%
-60.3%
1 Month
+31.7%
+31.7%
3 Month
+17.2%
+17.2%
6 Month
-6.1%
-6.1%
1 Year
-82.0%
-82.0%

More News

Read More
News headline image
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026
From Ensysce Biosciences
Via ACCESS Newswire
Top stock movements in today's session. ↗
August 06, 2026
Via Chartmill
Thursday's session: most active stocks ↗
August 06, 2026
Via Chartmill
News headline image
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
June 26, 2026
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 06, 2026
Via Benzinga
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
August 06, 2026
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
August 06, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
August 06, 2026
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
August 06, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
August 06, 2026
Via Benzinga
News headline image
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
August 06, 2026
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
The Bull Lives Below $1: PRSO, ENSC, TNMG, QNME Stocks to Watch
August 04, 2026
Via AB Newswire
Topics Artificial Intelligence
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
August 04, 2026
Via Chartmill
These stocks are making the most noise in today's session. ↗
August 04, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
August 04, 2026
Via Chartmill
Tuesday's pre-market session: top gainers and losers ↗
August 04, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 04, 2026
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 03, 2026
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. ↗
August 03, 2026
Via Chartmill
News headline image
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
July 14, 2026
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports First Quarter 2026 Financial Results
May 15, 2026
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
May 12, 2026
Via ACCESS Newswire
Check out the stocks that are attracting the most attention and driving market activity. ↗
May 11, 2026
Via Chartmill

Frequently Asked Questions

Is Ensysce Biosciences, Inc. - Common Stock publicly traded?
Yes, Ensysce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ensysce Biosciences, Inc. - Common Stock trade on?
Ensysce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ensysce Biosciences, Inc. - Common Stock?
The ticker symbol for Ensysce Biosciences, Inc. - Common Stock is ENSC on the Nasdaq Stock Market
What is the current price of Ensysce Biosciences, Inc. - Common Stock?
The current price of Ensysce Biosciences, Inc. - Common Stock is 0.3733
When was Ensysce Biosciences, Inc. - Common Stock last traded?
The last trade of Ensysce Biosciences, Inc. - Common Stock was at 08/21/26 04:00 PM ET
What is the market capitalization of Ensysce Biosciences, Inc. - Common Stock?
The market capitalization of Ensysce Biosciences, Inc. - Common Stock is 1.32M
How many shares of Ensysce Biosciences, Inc. - Common Stock are outstanding?
Ensysce Biosciences, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap